[go: up one dir, main page]

GB9520584D0 - Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same - Google Patents

Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Info

Publication number
GB9520584D0
GB9520584D0 GBGB9520584.5A GB9520584A GB9520584D0 GB 9520584 D0 GB9520584 D0 GB 9520584D0 GB 9520584 A GB9520584 A GB 9520584A GB 9520584 D0 GB9520584 D0 GB 9520584D0
Authority
GB
United Kingdom
Prior art keywords
processes
preparation
same
pharmaceutical composition
pyrazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9520584.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to GBGB9520584.5A priority Critical patent/GB9520584D0/en
Publication of GB9520584D0 publication Critical patent/GB9520584D0/en
Priority to ZA968286A priority patent/ZA968286B/en
Priority to PCT/JP1996/002919 priority patent/WO1997013755A1/en
Priority to EP96932841A priority patent/EP0856000A1/en
Priority to JP9514909A priority patent/JPH11513403A/en
Priority to CA002234511A priority patent/CA2234511A1/en
Priority to CN96198649A priority patent/CN1203589A/en
Priority to AU71461/96A priority patent/AU7146196A/en
Priority to KR1019980702464A priority patent/KR19990063989A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9520584.5A 1995-10-09 1995-10-09 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same Pending GB9520584D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB9520584.5A GB9520584D0 (en) 1995-10-09 1995-10-09 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
ZA968286A ZA968286B (en) 1995-10-09 1996-10-02 Novel compounds
PCT/JP1996/002919 WO1997013755A1 (en) 1995-10-09 1996-10-08 1,3,5-trisubstituted pyrazoles for treament of inflammation
EP96932841A EP0856000A1 (en) 1995-10-09 1996-10-08 1,3,5-trisubstituted pyrazoles for treament of inflammation
JP9514909A JPH11513403A (en) 1995-10-09 1996-10-08 1,3,5-Trisubstituted pyrazole compounds for treating inflammation
CA002234511A CA2234511A1 (en) 1995-10-09 1996-10-08 1,3,5-trisubstituted pyrazoles for treatment of inflammation
CN96198649A CN1203589A (en) 1995-10-09 1996-10-08 new compound
AU71461/96A AU7146196A (en) 1995-10-09 1996-10-08 1,3,5-trisubstituted pyrazoles for treament of inflammation
KR1019980702464A KR19990063989A (en) 1995-10-09 1996-10-08 1,3,5-trisubstituted pyrazole compounds for the treatment of inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9520584.5A GB9520584D0 (en) 1995-10-09 1995-10-09 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
GB9520584D0 true GB9520584D0 (en) 1995-12-13

Family

ID=10782007

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9520584.5A Pending GB9520584D0 (en) 1995-10-09 1995-10-09 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Country Status (9)

Country Link
EP (1) EP0856000A1 (en)
JP (1) JPH11513403A (en)
KR (1) KR19990063989A (en)
CN (1) CN1203589A (en)
AU (1) AU7146196A (en)
CA (1) CA2234511A1 (en)
GB (1) GB9520584D0 (en)
WO (1) WO1997013755A1 (en)
ZA (1) ZA968286B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE9900517A (en) * 1997-04-18 2000-06-15 G.D. Searle & Co. A method of using cyclooxygenase-2 inhibitors for the prevention of cardiovascular disease
US5886191A (en) * 1997-08-18 1999-03-23 Dupont Pharmaceuticals Company Amidinoindoles, amidinoazoles, and analogs thereof
AUPO941497A0 (en) 1997-09-24 1997-10-16 Fujisawa Pharmaceutical Co., Ltd. Novel compounds
AUPP042397A0 (en) * 1997-11-18 1997-12-11 Fujisawa Pharmaceutical Co., Ltd. 5-arylpyrazole compounds
US6887893B1 (en) 1997-12-24 2005-05-03 Sankyo Company, Limited Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
ES2137138B1 (en) * 1998-05-29 2000-09-16 Esteve Labor Dr DERIVATIVES OF PIRAZOLINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINES.
US6506747B1 (en) * 1998-06-05 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
US6727238B2 (en) 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
US6294558B1 (en) 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
WO2000018741A2 (en) * 1998-09-30 2000-04-06 Fujisawa Pharmaceutical Co., Ltd. Pyrazole compounds as cox-2 inhibitors
WO2001016138A1 (en) * 1999-08-27 2001-03-08 Abbott Laboratories Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
ES2200787T3 (en) 1999-12-03 2004-03-16 Pfizer Products Inc. ACETYLENE DERIVATIVES AS ANTI-INFLAMMATORY / ANALGESIC AGENTS.
MXPA02005539A (en) 1999-12-03 2002-09-02 Pfizer Prod Inc Heterocyclo alkylsulfonyl pyrazole derivatives as anti inflammatory analgesic agents.
PT1104760E (en) 1999-12-03 2003-06-30 Pfizer Prod Inc SULFAMOYL-HETEROARILPIRAZOLE COMPOUNDS AS ANALGESIC AND ANTI-INFLAMMATORY AGENTS
ATE252576T1 (en) 1999-12-03 2003-11-15 Pfizer Prod Inc HETEROARYLPHENYLPYRAZOLE COMPOUNDS FOR USE AS ANALGESIC/ANTI-INFLAMMATORY AGENT
ATE298749T1 (en) 2001-07-05 2005-07-15 Pfizer Prod Inc HETEROCYCLO-ALKYLSULFONYL PYRAZOLES AS ANTI-INFLAMMATORY/ANALGESIC AGENTS
AR038957A1 (en) 2001-08-15 2005-02-02 Pharmacia Corp COMBINATION THERAPY FOR CANCER TREATMENT
GT200200183A (en) 2001-09-28 2003-05-23 PROCEDURE TO PREPARE DERIVATIVES OF HETEROCICLOALQUILSULFONIL PIRAZOL
WO2003037336A1 (en) 2001-11-02 2003-05-08 Pfizer Products Inc. 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
AU2003279622A1 (en) 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
PT1572173E (en) 2002-12-13 2010-05-10 Warner Lambert Co Alpha-2-delta ligand to treat lower urinary tract symptoms
WO2005079808A1 (en) 2004-01-22 2005-09-01 Pfizer Limited Triazole derivatives which inhibit vasopressin antagonistic activity
ES2257929B1 (en) * 2004-07-16 2007-05-01 Laboratorios Del Dr. Esteve, S.A. DERIVATIVES OF PIRAZOLINA, PROCEDURE FOR OBTAINING AND USING THE SAME AS THERAPEUTIC AGENTS.
CN101600458A (en) 2006-12-22 2009-12-09 瑞蔻达蒂爱尔兰有限公司 Combination therapy of lower urinary tract diseases with α2δ ligands and NSAIDs
CA2880542C (en) * 2012-07-30 2018-01-02 The Ohio State University Antibacterial protein kinase inhibitors
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
IL104311A (en) * 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
CZ294630B6 (en) * 1993-11-30 2005-02-16 G. D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
JPH10509140A (en) * 1994-11-08 1998-09-08 エーザイ株式会社 Pyrazole derivatives

Also Published As

Publication number Publication date
ZA968286B (en) 1997-05-13
AU7146196A (en) 1997-04-30
JPH11513403A (en) 1999-11-16
EP0856000A1 (en) 1998-08-05
CN1203589A (en) 1998-12-30
KR19990063989A (en) 1999-07-26
WO1997013755A1 (en) 1997-04-17
CA2234511A1 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
GB9520584D0 (en) Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
HUP0001115A3 (en) Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
IL102946A0 (en) Pyrazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP9602122A3 (en) Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
AU7640696A (en) Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
HUP9601176A3 (en) Amidine derivatives having adhesion-receptor antagonistic effect, pharmaceutical compositions containing the same and process for their preparation
HRP980258B1 (en) New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them
AU6062498A (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
HUT76052A (en) Azole derivatives having adhesion-receptor antagonistic effect, process for their preparation and pharmaceutical compositions containing the same
IL117495A0 (en) Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
GB9123353D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL104471A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same